Antithrombotic Regulation in Human Endothelial Cells by Fibrinolytic Factors

ABSTRACT

Vascular endothelial cells (ECs) modulate the blood fibrinolytic system by secreting tissue-type plasminogen activator (t-PA), urokinase-type plasminogen activator (u-PA), and their inhibitor, type-1 plasminogen activator inhibitor (PAI-1). ECs also express t-PA receptors (t-PAR) and u-PA receptors (u-PAR) on their cell surfaces, assembling both enzymes to regulate the cellular fibrinolytic activity. In addition, ECs modulate these factors in response to several stimuli. Fibrin clots on ECs induce the up- and downregulation of t-PA and PAI-1 production, respectively, thus causing an effective lysis of the fibrin clot. Heat shock (43°C) increases the expression of u-PA, t-PA, PAI-1, and u-PAR by which ECs become more fibrinolytic around the cells. Furthermore, because ECs possess t-PAR and u-PAR on their cell surfaces, the binding of t-PA and u-PA is a critical event, which affords ECs the localized and condensed fibrinolytic potential. Therefore, ECs play a central role in antithrombotic activity by regulating the levels of these fibrinolytic factors.

KEYWORD

Endothelial cells - t-PA receptor - u-PA receptor - type 1 plasminogen activator inhibitor - antithrombotic activity

REFERENCES

• 1 Holmes W E, Pennica D, Blaber M. Cloning and expression of the gene for pro-urokinase in Escherichia coli .  Biotechnology. 1995;  3 923-928
• 2 Ny T, Elgh F, Lund B. The structure of the human tissue-type plasminogen activator gene. Correlation of intron and exon structures to functional and structural domains.  Proc Natl Acad Sci USA . 1984;  81 5355-5359
• 3 Loskutoff D J, Edgington T E. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.  Proc Natl Acad Sci USA . 1977;  74 3903-3907
• 4 Fukao H, Ueshima S, Okada K. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.  Thromb Res . 1992;  68 57-65
• 5 Konkle B A, Ginsburg D. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.  J Clin Invest . 1988;  82 579-585
• 6 Konkle B A, Kollrons P R, Kelly M D. Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression: Interaction with cAMP and protein kinase C-mediated pathways.  J Biol Chem . 1990;  265 21867-21873
• 7 Schleef R R, Bevilacqua M P, Sawdey M, Gimbrone Jr A M, Loskutoff D J. Cytokine activation of vascular endothelium: Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.  J Biol Chem . 1988;  263 5797-5803
• 8 Martin N B, Jamieson A, Tuffin D P. The effect of interleukin-4 on tumor necrosis factor-alpha induced expression of tissue factor and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells.  Thromb Haemost . 1993;  70 1037-1042
• 9 Patridge C A, Gerritsen M E. Dexamethasone increases the release of three 44kDa proteins immunologically related to plasminogen activator inhibitor-1 from human umbilical vein endothelial and rabbit coronary microvessel endothelial cells.  Thromb Res . 1990;  57 139-154
• 10 Hanss M, Collen D. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: Modulation by thrombin, endotoxin, and histamine.  J Lab Clin Med . 1987;  109 97-104
• 11 Bergonzelli G E, Kruithof E KO. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.  J Cell Physiol . 1991;  148 306-313
• 12 Wojta J, Holzer M, Hufnagl P. Hyperthermia stimulates plasminogen activator inhibitor type 1 expression in human umbilical vein endothelial cells in vitro.  Am J Pathol . 1991;  139 911-919
• 13 Roldan A L, Cubellis M V, Masucci M T. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.  EMBO J . 1990;  9 467-474
• 14 Danø K, Behrendt N, Brunner N. The urokinase receptor: Protein structure and role in plasminogen activation and cancer invasion.  Fibrinolysis . 1994;  8 189-203
• 15 Fukao H, Hagiya Y, Nonaka T, Okada K, Matsuo O. Analysis of binding protein for tissue-type plasminogen activator in human endothelial cells.  Biochem Biophys Res Commun . 1992;  187 956-962
• 16 Hajjar K A, Jacovina A T, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator: I. Identity with annexin II.  J Biol Chem . 1994;  269 21191-21197
• 17 Fukao H, Ueshima S, Okada K, Matsuo O. The role of the pericellular fibrinolytic system in angiogenesis.  Jpn J Physiol . 1997;  47 161-171
• 18 Schleef R R, Podor T J, Dunne E, Mimuro J, Loskutoff D J. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.  J Cell Biol . 1990;  110 155-163
• 19 Jaffe E A, Hoyer L W, Nachman R L. Synthesis of antihemophilic factor antigen by cultured human endothelial cells.  J Clin Invest . 1973;  52 2757-2764
• 20 Matsuo O, Sakai T, Bando H. Plasminogen activator in bronchoalveolar fluid.  Haemostasis . 1986;  16 43-50
• 21 Fukao H, Ueshima S, Tanaka N, Okada K, Matsuo O. Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cells.  Thromb Res . 1990;  11-20 (11-20)
• 22 Fukao H, Matsumoto H, Ueshima S, Okada K, Matsuo O. Effects of fibrin on the secretion of plasminogen activator inhibitor-1 from endothelial cells and on protein kinase C.  Life Sci . 1995;  57 1267-1276
• 23 Fukao H, Hagiya Y, Ueshima S. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.  Thromb Haemost . 1996;  75 352-358
• 24 Fukao H, Ueshima S, Takaishi T, Okada K, Matsuo O. Enhancement of tissue-type plasminogen activator (t-PA) activity by purified t-PA receptor expressed in human endothelial cells.  Biochim Biophys Acta . 1997;  1356 111-120